CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

A Phase 2 long-term safety study of GS-6624 in adults with idiopathic pulmonary fibrosis has been terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Gilead Sciences | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: TERMINATED | Results posted: 2017-04-04